There’s a lot to look forward to.

Testing our products to prove clinical efficacy is one of our core values, and something that sets us apart in the industry. Due to successful results in the first phase of our study on the effects of our Lycored Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project. The results of the study showed that subjects who ingested our blend had significantly reduced systolic and diastolic blood pressures and increased retinal capillary blood flow markers. Professor Alon Harris, principal clinical study investigator, believes that “these initial results of the […] study showcase the importance of the development of supplements for eyes and where the future of the vision health industry is heading.” We hope to keep the promising results coming, and we’re excited to see what phase two brings.